476 related articles for article (PubMed ID: 29367258)
1. Identifying Functional Hotspot Residues for Biased Ligand Design in G-Protein-Coupled Receptors.
Nivedha AK; Tautermann CS; Bhattacharya S; Lee S; Casarosa P; Kollak I; Kiechle T; Vaidehi N
Mol Pharmacol; 2018 Apr; 93(4):288-296. PubMed ID: 29367258
[TBL] [Abstract][Full Text] [Related]
2. Simulations of biased agonists in the β(2) adrenergic receptor with accelerated molecular dynamics.
Tikhonova IG; Selvam B; Ivetac A; Wereszczynski J; McCammon JA
Biochemistry; 2013 Aug; 52(33):5593-603. PubMed ID: 23879802
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of pepducins as Gs-biased allosteric agonists.
Carr R; Du Y; Quoyer J; Panettieri RA; Janz JM; Bouvier M; Kobilka BK; Benovic JL
J Biol Chem; 2014 Dec; 289(52):35668-84. PubMed ID: 25395624
[TBL] [Abstract][Full Text] [Related]
4. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
[TBL] [Abstract][Full Text] [Related]
5. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.
DeVree BT; Mahoney JP; Vélez-Ruiz GA; Rasmussen SG; Kuszak AJ; Edwald E; Fung JJ; Manglik A; Masureel M; Du Y; Matt RA; Pardon E; Steyaert J; Kobilka BK; Sunahara RK
Nature; 2016 Jul; 535(7610):182-6. PubMed ID: 27362234
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms of Diverse Activation Stimulated by Different Biased Agonists for the β2-Adrenergic Receptor.
Chen J; Liu J; Yuan Y; Chen X; Zhang F; Pu X
J Chem Inf Model; 2022 Nov; 62(21):5175-5192. PubMed ID: 34802238
[TBL] [Abstract][Full Text] [Related]
8. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
[TBL] [Abstract][Full Text] [Related]
9. Biased Signaling of the G-Protein-Coupled Receptor β
Lamichhane R; Liu JJ; White KL; Katritch V; Stevens RC; Wüthrich K; Millar DP
Structure; 2020 Mar; 28(3):371-377.e3. PubMed ID: 31978323
[TBL] [Abstract][Full Text] [Related]
10. Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening?
Tang H; Wang XS; Hsieh JH; Tropsha A
Proteins; 2012 Jun; 80(6):1503-21. PubMed ID: 22275072
[TBL] [Abstract][Full Text] [Related]
11. Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor.
Weiss DR; Ahn S; Sassano MF; Kleist A; Zhu X; Strachan R; Roth BL; Lefkowitz RJ; Shoichet BK
ACS Chem Biol; 2013 May; 8(5):1018-26. PubMed ID: 23485065
[TBL] [Abstract][Full Text] [Related]
12. Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.
Staus DP; Strachan RT; Manglik A; Pani B; Kahsai AW; Kim TH; Wingler LM; Ahn S; Chatterjee A; Masoudi A; Kruse AC; Pardon E; Steyaert J; Weis WI; Prosser RS; Kobilka BK; Costa T; Lefkowitz RJ
Nature; 2016 Jul; 535(7612):448-52. PubMed ID: 27409812
[TBL] [Abstract][Full Text] [Related]
13. Unique Positive Cooperativity Between the
Pani B; Ahn S; Rambarat PK; Vege S; Kahsai AW; Liu A; Valan BN; Staus DP; Costa T; Lefkowitz RJ
Mol Pharmacol; 2021 Nov; 100(5):513-525. PubMed ID: 34580163
[TBL] [Abstract][Full Text] [Related]
14. G-Protein/β-Arrestin-Linked Fluctuating Network of G-Protein-Coupled Receptors for Predicting Drug Efficacy and Bias Using Short-Term Molecular Dynamics Simulation.
Ichikawa O; Fujimoto K; Yamada A; Okazaki S; Yamazaki K
PLoS One; 2016; 11(5):e0155816. PubMed ID: 27187591
[TBL] [Abstract][Full Text] [Related]
15. Does Divergent Binding Pocket Closure Drive Ligand Bias for Class A GPCRs?
Bermudez M; Bock A
Trends Pharmacol Sci; 2019 Apr; 40(4):236-239. PubMed ID: 30852058
[TBL] [Abstract][Full Text] [Related]
16. Small-Molecule Positive Allosteric Modulators of the
Ahn S; Pani B; Kahsai AW; Olsen EK; Husemoen G; Vestergaard M; Jin L; Zhao S; Wingler LM; Rambarat PK; Simhal RK; Xu TT; Sun LD; Shim PJ; Staus DP; Huang LY; Franch T; Chen X; Lefkowitz RJ
Mol Pharmacol; 2018 Aug; 94(2):850-861. PubMed ID: 29769246
[TBL] [Abstract][Full Text] [Related]
17. The role of conformational ensembles of seven transmembrane receptors in functional selectivity.
Vaidehi N; Kenakin T
Curr Opin Pharmacol; 2010 Dec; 10(6):775-81. PubMed ID: 20933468
[TBL] [Abstract][Full Text] [Related]
18. Modeling G protein-coupled receptors in complex with biased agonists.
Costanzi S
Trends Pharmacol Sci; 2014 Jun; 35(6):277-83. PubMed ID: 24793542
[TBL] [Abstract][Full Text] [Related]
19. Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs.
McCorvy JD; Butler KV; Kelly B; Rechsteiner K; Karpiak J; Betz RM; Kormos BL; Shoichet BK; Dror RO; Jin J; Roth BL
Nat Chem Biol; 2018 Feb; 14(2):126-134. PubMed ID: 29227473
[TBL] [Abstract][Full Text] [Related]
20. Biased Signaling in Mutated Variants of β
Madhu MK; Shewani K; Murarka RK
J Chem Inf Model; 2024 Jan; 64(2):449-469. PubMed ID: 38194225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
